Novo Nordisk A/S
NVO
#89
Rank
$208.628 B
Marketcap
Denmark
Country
$47.19
Share price
0.04%
Change (1 day)
-32.56%
Change (1 year)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare…
Key Metrics
Trailing P/E
10.66
Forward P/E
1.97
EPS (TTM)
$4.05
Forward EPS
$3.38
Price / Book
5.59
EV / EBITDA
1.6x
Beta
0.34
Dividend Yield
4.31%
Return on Equity
59.81%
Return on Assets
18.73%
Debt / Equity
63.33
Current Ratio
0.87
Gross Margin
81.99%
Operating Margin
42.54%
Net Profit Margin
35.35%
Free Cash Flow
$37.673B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 18 – Sep 17
-5.55%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$47.090B
Latest Net Income$15.607B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Novo Nordisk A/S with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
NVO
No recent news available. Set FINNHUB_API_KEY to enable news.
